🔎 Trials Near Me

ホーム › 潰瘍性大腸炎 › テキサス

テキサスにおける潰瘍性大腸炎の臨床試験

テキサス内の拠点で、潰瘍性大腸炎に関する34件の研究が参加者を募集しています。

テキサス内の都市

公式研究テキスト(英語)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Novel Research - Bellaire /ID# 280925, Bellaire
  • Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas
  • Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
  • 他9件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • The Clinical Trials Network CTNX LLC, El Paso
  • Amel Med LLC, Georgetown
  • Kelsey Research Foundation, Houston
  • 他7件
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328

Confirmatory Clinical Study in Active Ulcerative Colitis

  • Southern Star Research Institute, San Antonio
被験者募集中第2相
16歳以上 · 全性別 · 2026/09/30更新 · NCT07296315

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

  • University of Texas - Southwestern Medical Center /ID# 271835, Dallas
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/30更新 · NCT07071519

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Inquest Clinical Research, Baytown
  • DHR Health Gastroenterology - Edinburg, Edinburg
  • Baylor College of Medicine, Houston
  • 他3件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Cedar Park
  • Xencor Investigative Site, Denton
  • Xencor Investigative Site, Garland
  • 他8件
被験者募集中第1/2相健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 013, Cedar Park
  • Site 005, Garland
  • Site 002, San Antonio
  • 他2件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-024, Garland
  • Site US-009, Georgetown
  • Site US-030, Houston
  • 他4件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07845487

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • The University of Texas at Austin, Austin
  • DFW Clinical Trials, Carrollton
  • Victorium Clinical Research, Houston
  • 他3件
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT07196748

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  • Cook Childrens Medical Center, Fort Worth
被験者募集中第3相
3歳以上 · 全性別 · 2026/09/25更新 · NCT06663332

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Local Institution - 0103, Fort Worth
  • Texas Children's Hospital, Houston
被験者募集中第2/3相
2歳〜17歳 · 全性別 · 2026/09/24更新 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
  • Tyler Research Institute, Tyler
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  • One of a Kind Clinical Research Center - Kingwood, Kingwood
  • Southern Star Research Institute, San Antonio
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Cook Children's Medical Center, Fort Worth
被験者募集中第3相
2歳〜19歳 · 全性別 · 2026/09/22更新 · NCT04844606

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Texas Digestive Disease Consultants - Cedar Park, Cedar Park
  • GI Alliance - Dallas - Gaston Avenue, Dallas
  • GI Alliance - Fort Worth, Fort Worth
  • 他5件
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • GI Alliance - Fort Worth, Fort Worth
  • GI Alliance - Garland, Garland
  • Integrity Advanced Therapeutics, Houston
  • 他4件
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • GI Alliance - Digestive Health Associates of Texas, Dallas
  • The University of Texas Health Science Center at Houston, Houston
  • GI Alliance - Mansfield, Mansfield
  • 他4件
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/09/21更新 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • GI Alliance - Lubbock - Site Number: 8400092, Lubbock
  • Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
  • Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101, Southlake
  • 他1件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07185009

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

  • GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
  • GI Alliance - Lubbock ( Site 0288), Lubbock
  • Caprock Gastro Research ( Site 0293), Lubbock
  • 他3件
被験者募集中第3相
全年齢 · 全性別 · 2026/09/09更新 · NCT06651281

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  • Southern Star Research Institute, LLC, San Antonio
  • Tyler Research Institute, LLC, Tyler
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07577856

A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

  • BAMC, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/28更新 · NCT04372108

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

  • Texas Digestive Disease Consultants, Cedar Park
  • Baylor College of Medicine, Houston
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/08/21更新 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Inquest Clinical Research - Site Number: 8400144, Baytown
  • The University of Texas Southwestern Medical Center - Site Number: 8400098, Dallas
  • Valley Institute of Research - Site Number: 8400004, Harlingen
  • 他7件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • University of Texas Southwestern, Dallas
  • Baylor College of Medicine, Houston
被験者募集中
18歳以上 · 全性別 · 2026/08/07更新 · NCT05230173

BOOM-IBD2 Pivotal Clinical Trial

  • Amarillo Premier Research (Objective Health), Amarillo
  • Digestive Research of Central Texas (Objective Health), Waco
被験者募集中
18歳〜85歳 · 全性別 · 2026/08/06更新 · NCT06571669

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

  • Houston Endoscopy & Research Center, Houston
  • BI Research Center, Houston
  • Brooke Army Medical center, San Antonio
  • 他2件
被験者募集中観察研究
18歳〜64歳 · 全性別 · 2026/07/09更新 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

  • ACT-Midwest G1, Abilene
被験者募集中第2相
12歳〜17歳 · 全性別 · 2026/07/08更新 · NCT05287126

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

  • Tyler Research Institute, LLC, Tyler
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/05/22更新 · NCT06764615

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

  • M D Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/20更新 · NCT04751396

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Texas Children's Hospital - Baylor - PIN, Houston
被験者募集中第3相
2歳以上 · 全性別 · 2026/05/07更新 · NCT05442567

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

  • Investigational Site Number: 8400023, Houston
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/04/23更新 · NCT06975722

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Dallas
  • Mirador Therapeutics Selected Site, Garland
  • Mirador Therapeutics Selected Site, Georgetown
  • 他5件
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522

Registry and Biorepository for IBD in Central Texas

  • Dell Medical School, UT Austin, Austin
被験者募集中観察研究
18歳〜100歳 · 全性別 · 2021/05/18更新 · NCT04617184

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。